Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives -- Ignore unavailable to you. Want to Upgrade?

To: cycleupcycledown who wrote (123606)	4/25/2019 11:05:03 PM
From: GROUND ZERO™	1 Recommendation Recommended By SGJ Read Replies (2) \| Respond to of 222044

CGC look promising... GZ

To: cycleupcycledown who wrote (123606)	4/25/2019 11:07:01 PM
From: robert b furman	1 Recommendation Recommended By SGJ Read Replies (1) \| Respond to of 222044

CGC, ACB, and a fav IIPR (reit) plus MO, the last 2 pay a dividend. One of my rules. Bob

To: cycleupcycledown who wrote (123606)	4/25/2019 11:19:11 PM
From: the longhorn	Respond to of 222044

Here's a whiskey play that has had quite a run. schrts.co . Looks a little toppy right now. lh

To: cycleupcycledown who wrote (123606)	4/26/2019 9:15:41 AM
From: yard_man	Read Replies (1) \| Respond to of 222044

just by the physical?? <g>

To: cycleupcycledown who wrote (123606)	4/26/2019 10:24:53 AM
From: da_cheif™	Respond to of 222044

where u been Message 32111002

To: cycleupcycledown who wrote (123606)	4/27/2019 12:45:39 PM
From: Winfastorlose	1 Recommendation Recommended By bull_dozer Read Replies (1) \| Respond to of 222044

I have been researching the industry for quite some time and here is my investment list of cannabis companies. ACB. (with Nelson Peltz as a board member and advisor. a huge plus). APHA (undervalued and with Irwin Simon as Chairman and interim CEO. A huge plus) STZ (with right to eventually control CGC) pays dividends & understands navigating regulatory hurdles MO (should eventually control CRON) pays dividends & understands navigating regulatory hurdles ACRGF (should eventually be bought out by CGC. with John Boehner as an advisor and board member) CWBHF (big in hemp & CBD oils and already profitable. A big plus) CTST (undervalued) TGODF (organic grower which should be important with upcoming edibles and CBD infused beverages) On my watch list. OGRMF (undervalued) CURLF TCNNF CNPOF (an acquisition arm for CGC) TLRY (needs to be cheaper, but has Peter Thiel, the paypal/facebook billionaire as a backer. This can not be overlooked) GWPH (overvalued right now, but doing CBD pharmaceutical research particularly as it pertains to epilepsy) Pay close attention to the connected companies. . This can not be overlooked. It is very important and these should be the companies that get most of your investment dollars dedicated to the sector. The industry will be controlled by the companies with the best political connections. The world is being divided up now. Legalization of both medical and recreational is in progress worldwide. All of the above is my opinion only and should not be construed as investment advice. It is simply the process I have used in determining my own allocations which I have deemed as suitable for me and me alone. .You should do your own research.

To: cycleupcycledown who wrote (123606)	4/28/2019 11:32:15 AM
From: Winfastorlose	Respond to of 222044

I probably should have added that in the end, I believe the story is going to come down to the following issues: Who can produce the most efficiently (either natural or synthetic). Who can extract the targeted substances the most efficiently. Who can create the most efficient and commercially viable drug delivery systems. Who can get licensed to operate in the most profitable markets. One can see that MO had all of this in mind when they went after CRON and then immediately took an expensive stake in JUUL shortly thereafter. (smoking the substance will likely be one of the least used delivery methods of all because it delivers so much less of the targeted substance than other delivery methods such as vaping, eating or drinking it since much of the THC or CBD is destroyed by the fire, leaves an odor on the user and is irritating to the lungs). This was immediately followed by CRON doing a deal with a synthetic research company which is trying to produce less expensive synthetic THC and CBD from yeast. ACB is also trying to create an "in house" vertically integrated company.